Related Experiment Videos
Robust deep learning for incomplete MRI sequences in glioma grading and IDH mutation status prediction: a large-scale
Fangrong Liang1,2, Jing Yan3, Shengsheng Lai4
1Department of Radiology, School of Medicine, The Second Affiliated Hospital of South China University of Technology (Guangzhou First People's Hospital), Guangzhou, China.
European Radiology
|May 16, 2026
Summary
A new model, RISEN, accurately predicts glioma grade and IDH mutation status even with incomplete MRI scans. This approach enhances diagnostic reliability in real-world clinical settings.
Area of Science:
- Neuro-oncology
- Medical Imaging
- Artificial Intelligence
Background:
- Incomplete multiparametric MRI (mp-MRI) sequences hinder the reliability of radiomics models for glioma grading and IDH mutation status prediction.
- Developing robust models that can handle missing data is crucial for clinical application.
Purpose of the Study:
- To develop a robust and noninvasive approach for accurate glioma grading and IDH mutation status prediction using incomplete MRI data.
- To evaluate the performance of the proposed model across various clinical scenarios with missing MRI sequences.
Main Methods:
- Retrospective collection of conventional MRI scans from 2170 glioma patients across multiple institutions and a public dataset.
- Utilizing a robust incomplete sequence estimation network (RISEN) to impute missing radiomic features and learn latent representations.
- Evaluating model performance using the area under the curve (AUC) in complete, simulated incomplete, and real-world missing-sequence scenarios.
Main Results:
- The optimal mp-MRI sequence combination (T1WI, CE-T1WI, T2-FLAIR) achieved high performance in complete datasets.
- RISEN demonstrated only moderate performance declines in simulated incomplete-sequence scenarios for both glioma grading and IDH prediction.
- The model showed comparable robustness in real-world datasets with missing sequences.
Conclusions:
- RISEN provides a robust and clinically applicable solution for glioma grading and IDH mutation prediction, even with incomplete mp-MRI data.
- The model's ability to handle missing sequences ensures consistent clinical decision-making and personalized therapy planning.